Antonio Collazo, MD
Otolaryngology · Marion, OHNPI 1013967371
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 21 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 12 manufacturers reported payments, led by Intersect ENT, Inc. at 31.9% of the total. That places this record below the midpoint for otolaryngology clinicians in OH, where the typical reported total is $1,058.
Across 21 payments — averaging $24.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intersect ENT, Inc.$162
- Sanofi$100
- Acclarent, Inc$39
- Stryker$35
- Merck$30
- Lucid Diagnostics Inc.$29
- plus $114 from 6 others
What the payments were for
- Food & beverage$508100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intersect ENT, Inc. | 2 | $162 |
| Sanofi | 5 | $100 |
| Acclarent, Inc | 1 | $39 |
| Stryker | 2 | $35 |
| Merck | 2 | $30 |
| Lucid Diagnostics Inc. | 2 | $29 |
| GSK | 2 | $28 |
| Checkpoint Surgical, Inc | 1 | $21 |
| Inspire Medical Systems, Inc. | 1 | $18 |
| Smith+Nephew | 1 | $17 |
| Regeneron Healthcare Solutions, Inc. | 1 | $17 |
| Optinose US, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- PROPEL$141
How this compares
$508 in reported general payments places this provider in the 35th percentile of 380 otolaryngology providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ipratropium Bromide | 227 | $5,239 |
| Famotidine | 570 | $4,937 |
| Neomycin-Polymyxin-HcNeomycin/Polymyxin B/Hydrocort | 81 | $3,825 |
| Fluticasone Propionate | 322 | $3,807 |
| Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth | 32 | $3,646 |
| Pantoprazole Sodium | 255 | $1,940 |
| Ofloxacin | 20 | $1,498 |
| Pilocarpine Hcl | 33 | $1,422 |
| Azelastine Hcl | 29 | $946 |
| Fluocinolone Acetonide Oil | 18 | $770 |
| Omeprazole | 67 | $758 |
| Lidocaine Hcl ViscousLidocaine Hcl | 18 | $578 |
| Doxycycline Hyclate | 48 | $514 |
| Triamcinolone Acetonide | 11 | $475 |
| Triamterene-HydrochlorothiazidTriamterene/Hydrochlorothiazid | 36 | $294 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology in Marion
- Raj SindwaniCleveland$598K
- Mark MehleCleveland$403K
- Troy WoodardCleveland$392K
- Oliver AdunkaColumbus$338K
- Subinoy DasColumbus$142K
- Sanjeet RangarajanCleveland$113K
- Sumit BapnaDublin$95K
- Boris KaranfilovDublin$82K
- Alexander DonathCincinnati$64K
- Rod RezaeeCleveland$54K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.